BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 10217657)

  • 1. Essential role of inducible nitric oxide synthase in monophosphoryl lipid A-induced late cardioprotection: evidence from pharmacological inhibition and gene knockout mice.
    Xi L; Jarrett NC; Hess ML; Kukreja RC
    Circulation; 1999 Apr; 99(16):2157-63. PubMed ID: 10217657
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Glycolipid RC-552 induces delayed preconditioning-like effect via iNOS-dependent pathway in mice.
    Xi L; Salloum F; Tekin D; Jarrett NC; Kukreja RC
    Am J Physiol; 1999 Dec; 277(6):H2418-24. PubMed ID: 10600864
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inducible nitric oxide synthase mediates delayed myocardial protection induced by activation of adenosine A(1) receptors: evidence from gene-knockout mice.
    Zhao T; Xi L; Chelliah J; Levasseur JE; Kukreja RC
    Circulation; 2000 Aug; 102(8):902-7. PubMed ID: 10952960
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pivotal role of nitric oxide in delayed pharmacological preconditioning against myocardial infarction.
    Xi L; Kukreja RC
    Toxicology; 2000 Nov; 155(1-3):37-44. PubMed ID: 11154795
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inducible nitric oxide synthase mediates delayed cardioprotection induced by morphine in vivo: evidence from pharmacologic inhibition and gene-knockout mice.
    Jiang X; Shi E; Nakajima Y; Sato S
    Anesthesiology; 2004 Jul; 101(1):82-8. PubMed ID: 15220775
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nitric oxide-dependent mechanism of anti-ischemic myocardial protection induced by monophosphoryl lipid A.
    Xi L
    Zhongguo Yao Li Xue Bao; 1999 Oct; 20(10):865-71. PubMed ID: 11270982
    [TBL] [Abstract][Full Text] [Related]  

  • 7. p38 Triggers late preconditioning elicited by anisomycin in heart: involvement of NF-kappaB and iNOS.
    Zhao TC; Taher MM; Valerie KC; Kukreja RC
    Circ Res; 2001 Nov; 89(10):915-22. PubMed ID: 11701619
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Preconditioning of swine heart with monophosphoryl lipid A improves myocardial preservation.
    Yoshida T; Engelman RM; Engelman DT; Rousou JA; Maulik N; Sato M; Elliott GT; Das DK
    Ann Thorac Surg; 2000 Sep; 70(3):895-900. PubMed ID: 11016330
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of inducible nitric oxide synthase in pharmacological "preconditioning" with monophosphoryl lipid A.
    Zhao L; Weber PA; Smith JR; Comerford ML; Elliott GT
    J Mol Cell Cardiol; 1997 Jun; 29(6):1567-76. PubMed ID: 9220342
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Morphine-induced late cardioprotection: potential role of inducible nitric oxide synthase].
    Shi EY; Jiang XJ; Bai H; Nakajima Y
    Zhonghua Yi Xue Za Zhi; 2004 Jun; 84(11):891-5. PubMed ID: 15329271
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Triggering role of nitric oxide in the delayed protective effect of monophosphoryl lipid A in rat heart.
    György K; Muller B; Vegh A; Kleschyov AL; Stoclet JC
    Br J Pharmacol; 1999 Aug; 127(8):1892-8. PubMed ID: 10482921
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reduction of myocardial infarct size by inhibition of inducible nitric oxide synthase.
    Wang D; Yang XP; Liu YH; Carretero OA; LaPointe MC
    Am J Hypertens; 1999 Feb; 12(2 Pt 1):174-82. PubMed ID: 10090345
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Induction of iNOS gene expression by monophosphoryl lipid A: a pharmacological approach for myocardial adaptation to ischemia.
    Maulik N; Tosaki A; Elliott GT; Maulik G; Das DK
    Drugs Exp Clin Res; 1998; 24(3):117-24. PubMed ID: 9825227
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Myocardial ischemia/reperfusion injury in the inducible nitric oxide synthase knockout mice.
    Xi L; Jarrett NC; Hess ML; Kukreja RC
    Life Sci; 1999; 65(9):935-45. PubMed ID: 10465353
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Preconditioning of rat heart with monophosphoryl lipid A: a role for nitric oxide.
    Tosaki A; Maulik N; Elliott GT; Blasig IE; Engelman RM; Das DK
    J Pharmacol Exp Ther; 1998 Jun; 285(3):1274-9. PubMed ID: 9618433
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Selective modulation of inducible nitric oxide synthase isozyme in myocardial infarction.
    Wildhirt SM; Suzuki H; Horstman D; Weismüller S; Dudek RR; Akiyama K; Reichart B
    Circulation; 1997 Sep; 96(5):1616-23. PubMed ID: 9315556
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Attenuation of myocardial ischemia/reperfusion injury by superinduction of inducible nitric oxide synthase.
    Kanno S; Lee PC; Zhang Y; Ho C; Griffith BP; Shears LL; Billiar TR
    Circulation; 2000 Jun; 101(23):2742-8. PubMed ID: 10851213
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Alpha-adrenergic receptor stimulation produces late preconditioning through inducible nitric oxide synthase in mouse heart.
    Tejero-Taldo MI; Gursoy E; Zhao TC; Kukreja RC
    J Mol Cell Cardiol; 2002 Feb; 34(2):185-95. PubMed ID: 11851358
    [TBL] [Abstract][Full Text] [Related]  

  • 19. NO-synthase inhibitors provide influence on protective effect of modified endotoxine diphosphoryl lipid A in a rat heart model of ischemic-reperfusion injury.
    Kuzelová M; Mladonická M; Bukovský M; Dubnicková M; Adameová A; Svec P
    Pharmazie; 2006 Jun; 61(6):568-70. PubMed ID: 16826982
    [TBL] [Abstract][Full Text] [Related]  

  • 20. COX-2 mediates morphine-induced delayed cardioprotection via an iNOS-dependent mechanism.
    Jiang X; Shi E; Nakajima Y; Sato S
    Life Sci; 2006 Apr; 78(22):2543-9. PubMed ID: 16325209
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.